K-RasG12D–induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to γ-secretase inhibitors
Open Access
- 15 October 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (8) , 3373-3382
Abstract
To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we made use of a conditional K-RasG12D murine knockin model, in which oncogenic K-Ras is expressed from its endogenous promoter. Transplantation of whole bone marrow cells that express oncogenic K-Ras into wild-type recipient mice resulted in a highly penetrant, aggressive T-cell leukemia/lymphoma. The lymphoblasts were composed of a CD4/CD8 double-positive population that aberrantly expressed CD44. Thymi of primary donor mice showed reduced cellularity, and immunophenotypic analysis demonstrated a block in differentiation at the double-negative 1 stage. With progression of disease, approximately 50% of mice acquired Notch1 mutations within the PEST domain. Of note, primary lymphoblasts were hypersensitive to γ-secretase inhibitor treatment, which is known to impair Notch signaling. This inhibition was Notch-specific as assessed by down-regulation of Notch1 target genes and intracellular cleaved Notch. We also observed that the oncogenic K-Ras-induced T-cell disease was responsive to rapamycin and inhibitors of the RAS/MAPK pathway. These data indicate that patients with T-cell leukemia with K-Ras mutations may benefit from therapies that target the NOTCH pathway alone or in combination with inhibition of the PI3K/AKT/MTOR and RAS/MAPK pathways.Keywords
This publication has 55 references indexed in Scilit:
- FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitorsJournal of Experimental Medicine, 2007
- The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemiaJournal of Experimental Medicine, 2007
- Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemiaBlood, 2007
- Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathwaysBlood, 2007
- A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ DeficiencyCell, 2007
- Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow MicroenvironmentCell, 2007
- Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivoBlood, 2006
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991